[1]
M. Andabaka, Šarlota Mesaroš, N. Veselinović, O. Tamaš, M. Budimkić, i P. J. Drulović, „NEUROMYELITIS OPTICA SPECTRUM DISORDERS: THERAPEUTIC CONSIDERATIONS: NMOSD therapeutic considerations“, medi, vol 58, izd. 1, Feb. 2025, doi: 10.5937/medi58-55665.